Global Gastritis Treatment Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Gastritis
![]() |
Gastritis Treatment Market |
The
global Gastritis Treatment Market is estimated to be valued at USD 162.2
million in 2021 and is expected to exhibit a CAGR of 4% over the forecast
period 2022-2029, as highlighted in a new report published by Coherent Market
Insights.
A) Market Overview:
Gastritis is a condition characterized by the inflammation of the lining of the
stomach. It can be caused by various factors such as infection, excessive
alcohol consumption, prolonged use of non-steroidal anti-inflammatory drugs
(NSAIDs), and autoimmune diseases. The Gastritis
Treatment Market products includes pharmaceutical drugs, proton pump
inhibitors (PPIs), H2 receptor antagonists, antacids, and antibiotics.
The need for gastritis treatment products arises due to the increasing
prevalence of gastritis worldwide. According to the World Gastroenterology
Organisation (WGO), gastritis affects approximately 50% of the global
population. The rising incidence of risk factors such as H. pylori infection,
unhealthy lifestyle habits, and the growing aging population contribute to the
increasing demand for gastritis treatment products.
B) Market Key Trends:
One key trend in the gastritis treatment market is the increasing adoption of
combination therapy. Combination therapy involves the simultaneous use of two
or more drugs to achieve a synergistic effect in treating gastritis. This
approach helps in improving treatment outcomes and reducing the risk of drug
resistance. For instance, a combination therapy of proton pump inhibitors and
antibiotics is often prescribed for the eradication of H. pylori infection. The
use of combination therapy is expected to drive market growth during the
forecast period.
C) PEST Analysis:
Political: Governments across the globe are taking initiatives to raise
awareness about gastrointestinal disorders and promote early diagnosis and
treatment. This creates a favorable political environment for the growth of the
gastritis treatment market.
Economic: The increasing prevalence of gastritis results in a higher demand for
treatment products, driving market growth. Additionally, the rising healthcare
expenditure and the availability of reimbursement for gastritis treatment
contribute to market expansion.
Social: Changing lifestyle habits, including unhealthy diet and excessive
alcohol consumption, contribute to the increasing incidence of gastritis
globally. The growing awareness about the importance of maintaining a healthy
lifestyle is expected to drive the demand for gastritis treatment products.
Technological: The development of advanced diagnostic techniques such as
endoscopy and molecular tests has improved the accuracy and efficiency of
gastritis diagnosis, leading to better treatment outcomes.
D) Key Takeaways:
1: The global gastritis treatment market is expected to witness high growth,
exhibiting a CAGR of 4% over the forecast period. This growth can be attributed
to increasing prevalence of gastritis and the rising demand for treatment
products. The market is driven by factors such as H. pylori infection,
unhealthy lifestyle habits, and the growing aging population.
2: In terms of regional analysis, North America is expected to dominate the
gastritis treatment market due to the high prevalence of gastritis in the
region. Asia Pacific is anticipated to be the fastest-growing region, owing to
the increasing healthcare expenditure and improving healthcare infrastructure
in countries like India and China.
3: Key players operating in the global gastritis treatment market include
Otsuka Indonesia PT, AstraZeneca PLC, Zydus Cadila Healthcare Limited, Novartis
AG, and others. These companies focus on product development, partnerships, and
collaborations to strengthen their market position.
In conclusion, the global gastritis treatment market is projected to grow
significantly over the forecast period. Increasing prevalence of gastritis and
the adoption of combination therapy are key trends driving market growth.
Political initiatives, economic factors, changing social habits, and
technological advancements further contribute to the expansion of the market.
North America is expected to dominate the market, while Asia Pacific is
anticipated to witness the highest growth. Key players in the market include
Otsuka Indonesia PT, AstraZeneca PLC, Zydus Cadila Healthcare Limited, and
Novartis AG, among others.
Comments
Post a Comment